Clinical Trials Search | Clareo Health

Showing 1-1 of 1 trials

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

NCT05660850

This Phase IIa, multicenter, randomized, double-blind, placebo-controlled, crossover study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamic (PD) effects of GDC-6599 compared with placebo in patients with a history of chronic cough.

Chronic Refractory Cough (CRC) With Non-atopic AsthmaCRC With Atopic AsthmaUnexplained Chronic Cough+2 more

Genentech, Inc.49 participantsStarted Mar 2023

Los Angeles, California, United States • Northridge, California, United States • Coral Gables, Florida, United States +15 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough